Stryker vs. Zimmer Biomet vs. J&J in Q3: How 3 orthopedic companies compare

Stryker, Johnson & Johnson and Zimmer Biomet posted their third-quarter financial results for 2024 and data on their spine orthopedic sales.

Advertisement

Here is how they compare:

Stryker

Total sales: $5.5 billion (+11.9%)

Orthopedics: $2.3 billion (10.7%)

Hips: $420 million (+15.9%)

Knees: $570 million (+10.6%)

Spine: $304 million (+4.6%)

Net gain: $834 million 

Zimmer Biomet

Total sales: $1.8 billion (+4%)

Hips: $481.5 million (+3.5%)

Knees: $745.1 million (+5.5%)

Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $464.2 million (+7.3%)

Net earnings: $249.1 million

Johnson & Johnson

Total sales: $22.5 billion (+5.2%)

Orthopedic: $2.2 billion (+1.2%)

Spine, sports and other: $696 million (-1.9%)

Hips: $381 million (+1.7%)

Knees: $352 million (+4%)

Net earnings: $2.7 billion

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.